Group structure
2 companies in 1 country
United States1
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
1–25 of 61
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALTOPREV10mg | 20mg | 40mg | 60mg · Tablet, extended release | Lovastatin | United States | Not marketed | 2002 |
| Alvesco 160 Inhalator, aërosol, oplossing 160 microgram/dosisAërosol, oplossing | Ciclesonide | Netherlands | Authorised | 2005 |
| ALVESCO 160 microgramos/INHALACION SOLUCION PARA INHALACION EN ENVASE A PRESION0,2 mg · Solución para inhalación en envase a presión | Ciclesonide | Spain | Marketed | 2009 |
| Alvesco 80 Inhalator, aërosol, oplossing 80 microgram/dosisAërosol, oplossing | Ciclesonide | Netherlands | Authorised | 2005 |
| ARYNTA10mg/ml · Solution | Lisdexamfetamine dimesylate | United States | Marketed | 2025 |
| AZMIRO200mg/ml (200mg/ml) · Solution | Testosterone | United States | Marketed | 2022 |
| BIDIL37.5mg; 20mg · Tablet | Hydralazine, Isosorbide dinitrate | United States | Marketed | 2005 |
| BRYNOVIN25mg base/ml · Solution | Sitagliptin | United States | Marketed | 2025 |
| DANZITEN71mg base | 95mg base · Tablet | Nilotinib | United States | Marketed | 2024 |
| DUAKLIR GENUAIR400 mcg / act + 12 mcg / act · Powder (Metered-Dose) | Aclidinium bromide, Formoterol | Canada | Marketed | 2015 |
| DUAKLIR PRESSAIR0.4mg/inh; 0.012mg/inh · Powder, metered | Aclidinium bromide, Formoterol | United States | Marketed | 2019 |
| E.E.S.200mg base · Tablet, chewable | Erythromycin | United States | Not marketed | 1970 |
| EDARBI40mg medoxomil | 80mg medoxomil · Tablet | Azilsartan kamedoxomil | United States | Marketed | 2011 |
| EDARBYCLOR40mg medoxomil; 12.5mg | 40mg medoxomil; 25mg · Tablet | Azilsartan kamedoxomil, Chlorthalidone | United States | Marketed | 2011 |
| EPANED1mg/ml · Solution | Enalapril | United States | Marketed | 2016 |
| EPANED KIT1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · For solution | Enalapril | United States | Not marketed | 2013 |
| EPRONTIA25mg/ml · Solution | Topiramate | United States | Marketed | 2021 |
| ERYPED200mg base · Tablet, chewable | Erythromycin | United States | Not marketed | 1970 |
| ERYTHROCIN STEARATE125mg base | 250mg base | 500mg base · Tablet | Erythromycin | United States | Not marketed | 1964 |
| EVEKEO10mg | 5mg · Tablet | Amfetamine | United States | Marketed | 2012 |
| EVEKEO ODT10MG | 15MG | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG | 5MG · Tablet, orally disintegrating | Amfetamine | United States | Not marketed | 2019 |
| FERABRIGHT300mg iron/10ml (eq 30mg iron/ml) | 510mg iron/17ml (eq 30mg iron/ml) · Solution | Ferumoxytol | United States | Marketed | 2025 |
| FERAHEME510mg iron/17ml (eq 30mg iron/ml) · Solution | Ferumoxytol | United States | Marketed | 2009 |
| FIRVANQ KIT25mg base/ml | 50mg base/ml · For solution | Vancomycin | United States | Marketed | 2018 |
| FLEQSUVY25mg/5ml · Suspension | Baclofen | United States | Marketed | 2022 |